Prid

Ichthammol, Calcium Sulfide, Calendula Officinalis Flowering Top, Arnica Montana, Echinacea Angustifolia, Silicon Dioxide, Sulfur


Hyland's Inc.
Human Otc Drug
NDC 54973-4069
Prid also known as Ichthammol, Calcium Sulfide, Calendula Officinalis Flowering Top, Arnica Montana, Echinacea Angustifolia, Silicon Dioxide, Sulfur is a human otc drug labeled by 'Hyland's Inc.'. National Drug Code (NDC) number for Prid is 54973-4069. This drug is available in dosage form of Salve. The names of the active, medicinal ingredients in Prid drug includes Arnica Montana - 3 [hp_X]/g Calcium Sulfide - 12 [hp_X]/g Calendula Officinalis Flowering Top - 3 [hp_X]/g Echinacea Angustifolia - 3 [hp_X]/g Ichthammol - 2 [hp_X]/g Silicon Dioxide - 12 [hp_X]/g Sulfur - 12 [hp_X]/g . The currest status of Prid drug is Active.

Drug Information:

Drug NDC: 54973-4069
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Prid
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Ichthammol, Calcium Sulfide, Calendula Officinalis Flowering Top, Arnica Montana, Echinacea Angustifolia, Silicon Dioxide, Sulfur
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Hyland's Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Salve
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ARNICA MONTANA - 3 [hp_X]/g
CALCIUM SULFIDE - 12 [hp_X]/g
CALENDULA OFFICINALIS FLOWERING TOP - 3 [hp_X]/g
ECHINACEA ANGUSTIFOLIA - 3 [hp_X]/g
ICHTHAMMOL - 2 [hp_X]/g
SILICON DIOXIDE - 12 [hp_X]/g
SULFUR - 12 [hp_X]/g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 Mar, 2022
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 21 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Hyland's Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0354973406919
UPC stands for Universal Product Code.
UNII:O80TY208ZW
1MBW07J51Q
18E7415PXQ
VB06AV5US8
NQ14646378
ETJ7Z6XBU4
70FD1KFU70
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
54973-4069-11 CAN in 1 CARTON (54973-4069-1) / 18 g in 1 CAN01 Mar, 2022N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

May help draw out splinters & ingrown hairs and temporarily relieve pain, itchiness and irritation from: boils, minor skin eruptions, bites superficial cuts or scratches

Product Elements:

Prid ichthammol, calcium sulfide, calendula officinalis flowering top, arnica montana, echinacea angustifolia, silicon dioxide, sulfur glycerin petrolatum alcohol yellow wax water stearyl alcohol rosin calcium sulfide calcium sulfide silicon dioxide silicon dioxide echinacea angustifolia echinacea angustifolia arnica montana arnica montana calendula officinalis flowering top calendula officinalis flowering top ichthammol ichthammol sulfur sulfur brown to dark brown

Indications and Usage:

Uses may help draw out splinters & ingrown hairs and temporarily relieve pain, itchiness and irritation from: ■ boils ■ minor skin eruptions ■ bites ■ superficial cuts or scratches

Warnings:

Warnings for external use only. do not use ■ in eyes, mouth and nose. ■ on deep puncture wounds. ■ on animal bites. ■ on serious burns. stop use and ask a doctor if ■ symptoms persist for more than 7 days or worsen. ■ irritation, pain, swelling or redness persists or worsens. if pregnant or breastfeeding ask a health professional before use. keep out of reach of children.

Do Not Use:

Warnings for external use only. do not use ■ in eyes, mouth and nose. ■ on deep puncture wounds. ■ on animal bites. ■ on serious burns. stop use and ask a doctor if ■ symptoms persist for more than 7 days or worsen. ■ irritation, pain, swelling or redness persists or worsens. if pregnant or breastfeeding ask a health professional before use. keep out of reach of children.

Dosage and Administration:

Directions adults and children 6 years and over ■ wash affected area with warm water, dry, and apply prid® twice daily on affected area and cover with a clean bandage until irritation subsides. ■ do not squeeze or pressure irritated skin. ■ do not use other than directed

Adults and children 6 years and over ■ wash affected area with warm water, dry, and apply prid® twice daily on affected area and cover with a clean bandage until irritation subsides. ■ do not squeeze or pressure irritated skin. ■ do not use other than directed

Stop Use:

Stop use and ask a doctor if ■ symptoms persist for more than 7 days or worsen. ■ irritation, pain, swelling or redness persists or worsens.

Package Label Principal Display Panel:

Package label #1 brand hyland's naturals prid pain relief & irritant drawing salve* drawing salve splinters, thorns, ingrown hairs pain, itch & irritation relief insect bites, boils, minor cuts or scrapes net wt. 0.63 oz. (18 g) homeopathic carton


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.